Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The 2001 Bethesda system.

Christine Bergeron1

  • 1Laboratoire Pasteur-Cerba, 95066 Cergy Pontolse, France. bergeron@pasteur-cerba.com

Salud Publica De Mexico
|January 30, 2004
PubMed
Summary

The Bethesda System for cervical cytology reporting was updated in 2001, refining terminology for better accuracy. Key changes include revised categories for atypical cells and new classifications for better cervical cancer screening.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Papillomavirus Testing and Size of CIN3: Implications for the Risk of Microinvasive Cervical Carcinoma.

Cancers·2026
Same author

Higher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesions.

EBioMedicine·2025
Same author

Use of p53 immunohistochemistry can improve diagnostic agreement for differentiated vulvar intraepithelial neoplasia (dVIN): an international reproducibility study.

Histopathology·2025
Same author

Should men whose female partners have cervical high grade intraepithelial lesion (HSIL) be screened?

European journal of obstetrics, gynecology, and reproductive biology·2025
Same author

[Management of women with abnormal cervical cytology: Update of INCa recommendations after the implementation of HPV screening].

Gynecologie, obstetrique, fertilite & senologie·2025
Same author

Vulvar biopsy: Punch biopsy or cervical forceps biopsy?

Journal of gynecology obstetrics and human reproduction·2023

Area of Science:

  • Gynecologic Pathology
  • Cytopathology
  • Cervical Cancer Screening

Background:

  • The Bethesda System (TBS) is the standard for reporting cervical cytology.
  • Established in 1988, TBS provides standardized terminology for cervical screening results.
  • Previous iterations of TBS required updates to reflect evolving diagnostic criteria.

Purpose of the Study:

  • To detail the modifications implemented in the April 2001 revision of The Bethesda System.
  • To highlight key changes in terminology and classification for cervical cytology reporting.
  • To provide updated guidelines for the interpretation of cervical cytology specimens.

Main Methods:

  • Review and analysis of the modifications introduced in the 2001 TBS update.
  • Comparison of the 2001 TBS terminology with previous versions.
  • Identification of significant changes in diagnostic categories and their implications.

Main Results:

  • Elimination of the "satisfactory but limited by" category.
  • Reintegration of benign changes into the "normal" category.
  • Renaming and subdivision of "atypical squamous cells of undetermined significance" (ASCUS) into "atypical squamous cells" (ASC) with further stratification.
  • Establishment of endocervical adenocarcinoma in situ as a distinct entity.
  • Low-grade and high-grade squamous intraepithelial lesions (LSIL/HSIL) categories remained unchanged.
  • Recommendations for automated review and ancillary testing were proposed.

Conclusions:

  • The 2001 revision of The Bethesda System offers a more precise and refined classification for cervical cytology.
  • These updates aim to improve diagnostic accuracy and consistency in reporting cervical abnormalities.
  • The revised system facilitates better patient management and follow-up for cervical cancer screening.

Related Experiment Videos